Literature DB >> 21212161

Phagocytosis of liposome particles by rat splenic immature monocytes makes them transiently and highly immunosuppressive in ex vivo culture conditions.

Daisuke Takahashi1, Hiroshi Azuma, Hiromi Sakai, Keitaro Sou, Daiko Wakita, Hideki Abe, Mitsuhiro Fujihara, Hirohisa Horinouchi, Takashi Nishimura, Koichi Kobayashi, Hisami Ikeda.   

Abstract

Liposomes reportedly accumulate in monophagocytic systems (MPSs), such as those of the spleen. Accumulation of considerable amounts of liposome in a MPS can affect immunologic response. While developing a liposomal oxygen carrier containing human hemoglobin vesicle (HbV), we identified its suppressive effect on the proliferation of rat splenic T cells. The aim of this study was to elucidate the mechanism underlying that phenomenon and its effect on both local and systemic immune response. For this study, we infused HbV intravenously at a volume of 20% of whole blood or empty liposomes into rats, removed their spleens, and evaluated T cell responses to concanavalin A (Con A) or keyhole limpet hemocyanin (KLH) by measuring the amount of [(3)H]thymidine incorporated into DNA. Cells that phagocytized liposomal particles were sorted using flow cytometry and analyzed. Serum anti-KLH antibody was measured after immunizing rats with KLH. Results showed that T cell proliferation in response to Con A or KLH was inhibited from 6 h to 3 days after the liposome injection. Direct cell-to-cell contact was necessary for the suppression. Both inducible nitric-oxide synthase and arginase inhibitors restored T cell proliferation to some degree. The suppression abated 7 days later. Cells that trapped vesicles were responsible for the suppression. Most expressed CD11b/c but lacked class II molecules. However, the primary antibody response to KLH was unaffected. We conclude that the phagocytosis of the large load of liposomal particles by rat CD11b/c+, class II immature monocytes temporarily renders them highly immunosuppressive, but the systemic immune response was unaffected.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212161     DOI: 10.1124/jpet.110.172510

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

Review 1.  Biocompatibility of HbV: Liposome-Encapsulated Hemoglobin Molecules-Liposome Effects on Immune Function.

Authors:  Hiroshi Azuma; Mitsuhiro Fujihara; Hiromi Sakai
Journal:  J Funct Biomater       Date:  2017-06-28

Review 2.  Overview of Potential Clinical Applications of Hemoglobin Vesicles (HbV) as Artificial Red Cells, Evidenced by Preclinical Studies of the Academic Research Consortium.

Authors:  Hiromi Sakai
Journal:  J Funct Biomater       Date:  2017-03-15

3.  Resuscitative efficacy of hemoglobin vesicles for severe postpartum hemorrhage in pregnant rabbits.

Authors:  Hiroki Ishibashi; Kohsuke Hagisawa; Manabu Kinoshita; Yukako Yuki; Morikazu Miyamoto; Tomoko Kure; Hiromi Sakai; Daizoh Saitoh; Katsuo Terui; Masashi Takano
Journal:  Sci Rep       Date:  2021-11-16       Impact factor: 4.379

4.  Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy.

Authors:  Natalie Cureton; Iana Korotkova; Bernadette Baker; Susan Greenwood; Mark Wareing; Venkata R Kotamraju; Tambet Teesalu; Francesco Cellesi; Nicola Tirelli; Erkki Ruoslahti; John D Aplin; Lynda K Harris
Journal:  Theranostics       Date:  2017-08-29       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.